Penicillin 'allergy' complicates inpatient care

Penicillin 'Allergy' complicates inpatient care

(HealthDay)—Patients with a history of penicillin "allergy," even though that may be inaccurate, spend more time in the hospital and have a greater risk of acquiring antibiotic-associated infections, according to research published in the Journal of Allergy and Clinical Immunology.

Eric Macy, M.D., of the Southern California Permanente Medical Group in San Diego, and Richard Contreras, of the Kaiser Permanente Health Care Program in Pasadena, Calif., conducted a retrospective, matched cohort study involving 51,582 subjects with penicillin "allergy" who were admitted to Kaiser Foundation hospitals in Southern California in 2010 through 2012. Each subject was matched to two control subjects by age, sex, date of admission, and discharge diagnosis.

The researchers found that patients labeled with , compared with control subjects, averaged 0.59 more total hospital days (95 percent confidence interval [CI], 0.47 to 0.71). Case subjects received treatment with significantly more of each of the following antibiotics: fluoroquinolones, clindamycin, and vancomycin. Compared with , case subjects experienced more Clostridium difficile infections (23.4 percent; 95 percent CI, 15.6 to 31.7 percent), methicillin-resistant Staphylococcus aureus infections (14.1 percent; 95 percent CI, 7.1 to 21.6 percent), and vancomycin-resistant Enterococcus infections (30.1 percent; 95 percent CI, 12.5 to 50.4 percent).

"A penicillin 'allergy' history, although often inaccurate, is not a benign finding at hospital admission," the authors write.

The Kaiser Permanente Health Care Program and ALK-Abelló funded the study. Both study authors disclosed financial ties to ALK-Abelló.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Psoriasis tied to 14 other autoimmune diseases

Jun 15, 2012

(HealthDay) -- Patients with psoriasis have significantly higher odds for having at least one of 14 other autoimmune diseases, according to a study published online June 4 in the Journal of the American Ac ...

Stage III/IV melanoma patients at risk for new primaries

Dec 10, 2013

(HealthDay)—Patients with stage III or IV melanoma who have not received treatment with BRAF inhibitors remain at risk for developing new primary melanomas (NPMs), although the incidence rates are lower ...

Melanoma risk up in IBD independent of biologic therapy

Jan 31, 2014

(HealthDay)—Inflammatory bowel disease (IBD) is associated with an increased risk of melanoma, independent of the use of biologic therapy, according to research published in the February issue of Clinical Ga ...

Metformin use doesn't cut incidence of bladder cancer

Feb 11, 2014

(HealthDay)—For patients with type 2 diabetes, metformin use is not associated with a significantly reduced risk of bladder cancer, according to a study published online Feb. 4 in Diabetes Care.

Recommended for you

Study unlocks basis of key immune protein's two-faced role

Nov 26, 2014

A Brigham and Women's Hospital-led team has identified a long sought-after partner for a key immune protein, called TIM-3, that helps explain its two-faced role in the immune system—sometimes dampening it, other times stimulating ...

Profilin can induce severe food-allergic reactions

Nov 25, 2014

(HealthDay)—Profilins are complete food allergens in food-allergic patient populations that are exposed to high levels of grass pollen, according to a study published in the December issue of Allergy.

Structured education program beneficial for anaphylaxis

Nov 21, 2014

(HealthDay)—A structured education intervention improves knowledge and emergency management for patients at risk for anaphylaxis and their caregivers, according to a study published online Nov. 19 in Allergy.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.